2nd paragraph of the AI says that DVIS is a new intended use and the the predicate does NOT use 3d fluoroscopy in its 3d function. Aside from the imagery and engineering issues brought up by AI and NSE. That may not be 100% deal breaker buts it close.
KKGuru, you mentioned $600M-700M min. for buy out.
That's a big difference from your earlier posts where you mentioned "$5 easy" and "$3-4 is easy after approval"
Any reason for the difference? The competition isn't really getting closer and dilution should be minimal (<5%). $600M-700M could be for just the patent...
Not trying to call you out, but just wondering if there was another reason I'm missing.